Synergy CHC Corp. (SNYR) financial statements (2022 and earlier)
Company profile
| Business Address |
865 SPRING STREET WESTBROOK, ME 04092 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| SIC | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 1,225 | 460 | 1,956 | 2,518 | 3,641 | 0 | ||
| Cash and cash equivalents | 1,225 | 460 | 1,956 | 2,518 | 3,641 | 0 | ||
| Receivables | 1,675 | 4,845 | 4,334 | 2,195 | 3,980 | 19 | ||
| Inventory, net of allowances, customer advances and progress billings | 1,861 | 2,670 | 2,842 | 1,103 | 687 | 26 | ||
| Inventory | 1,861 | 2,670 | 2,842 | 1,103 | 687 | 26 | ||
| Prepaid expense | 186 | 829 | 1,143 | 1,349 | 422 | 10 | ||
| Other undisclosed current assets | 100 | 136 | 139 | 100 | 607 | (0) | ||
| Total current assets: | 5,047 | 8,940 | 10,414 | 7,264 | 9,337 | 55 | ||
| Noncurrent Assets | ||||||||
| Property, plant and equipment | 136 | 270 | 293 | 257 | 12 | |||
| Intangible assets, net (including goodwill) | 8 | 10,801 | 13,325 | 12,939 | 17,412 | |||
| Goodwill | 7,793 | 7,793 | 7,793 | 11,496 | ||||
| Intangible assets, net (excluding goodwill) | 8 | 3,008 | 5,532 | 5,145 | 5,915 | |||
| Regulated entity, other noncurrent assets | 379 | |||||||
| Total noncurrent assets: | 144 | 11,071 | 13,619 | 13,196 | 17,803 | |||
| TOTAL ASSETS: | 5,191 | 20,011 | 24,033 | 20,460 | 27,139 | 55 | ||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities, including: | 4,674 | 8,397 | 4,329 | 4,559 | 5,032 | 75 | ||
| Accrued liabilities | 1,542 | 1,459 | 1,343 | 1,370 | 39 | 48 | ||
| Employee-related liabilities | 111 | 217 | 296 | 276 | 128 | 11 | ||
| Taxes payable | 314 | 180 | 95 | 973 | 911 | |||
| Interest and dividends payable | 147 | 31 | ||||||
| Other undisclosed accounts payable and accrued liabilities | 2,707 | 6,541 | 2,447 | 1,909 | 3,954 | 16 | ||
| Deferred revenue | 8 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Debt | 28 | (2,487) | 750 | 750 | 6 | |||
| Derivative instruments and hedges, liabilities | 3,096 | |||||||
| Due to related parties | 100 | |||||||
| Deferred revenue and credits | ✕ | ✕ | 3 | 36 | ||||
| Other liabilities | 2,552 | |||||||
| Other undisclosed current liabilities | 5,465 | 1,985 | 5,291 | 6,864 | 4,073 | |||
| Total current liabilities: | 10,147 | 10,411 | 7,135 | 12,209 | 15,503 | 181 | ||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 5,208 | |||||||
| Long-term debt, excluding current maturities | 5,208 | |||||||
| Liabilities, other than long-term debt | 247 | 5,629 | 7,464 | 830 | ||||
| Due to related parties | 247 | 5,629 | 7,464 | 830 | ||||
| Other undisclosed noncurrent liabilities | 314 | 1,009 | ||||||
| Total noncurrent liabilities: | 247 | 5,629 | 7,464 | 1,144 | 6,217 | |||
| Total liabilities: | 10,394 | 16,040 | 14,599 | 13,353 | 21,720 | 181 | ||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent, including: | (5,203) | 3,971 | 9,433 | 7,107 | 5,420 | (126) | ||
| Common stock | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Common stock, share subscribed but unissued, subscriptions receivable | 56 | 68 | 40 | |||||
| Additional paid in capital | 19,019 | 18,818 | 18,377 | 16,400 | 13,921 | 867 | ||
| Accumulated other comprehensive income (loss) | 11 | 179 | (78) | 16 | ||||
| Accumulated deficit | (24,235) | (15,027) | (8,866) | (9,366) | (8,570) | (1,033) | ||
| Other undisclosed stockholders' equity attributable to parent | 0 | |||||||
| Total stockholders' equity: | (5,203) | 3,971 | 9,433 | 7,107 | 5,420 | (126) | ||
| TOTAL LIABILITIES AND EQUITY: | 5,191 | 20,011 | 24,033 | 20,460 | 27,139 | 55 | ||
Income statement (P&L) ($ in thousands)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 29,358 | 33,824 | 35,596 | 34,840 | 13,456 | 9 | |
| Cost of revenue (Cost of Goods and Services Sold) | (9,138) | (12,474) | (9,818) | (10,205) | (5,308) | (6) | |
| Gross profit: | 20,220 | 21,350 | 25,778 | 24,635 | 8,148 | 4 | |
| Operating expenses | (28,176) | (26,268) | (23,955) | (21,701) | (7,662) | (962) | |
| Operating income (loss): | (7,956) | (4,918) | 1,822 | 2,934 | 486 | (958) | |
| Nonoperating income | 1,120 | 1,491 | 886 | 2,799 | 7,687 | ||
| Other nonoperating income | 1,491 | 1,007 | 2,785 | 7,633 | |||
| Interest and debt expense | (131) | (1,133) | 1,044 | 657 | 959 | (2) | |
| Income (loss) from continuing operations before equity method investments, income taxes: | (6,967) | (4,560) | 3,753 | 6,390 | 9,132 | (960) | |
| Other undisclosed loss from continuing operations before income taxes | (2,109) | (1,849) | (2,937) | (6,241) | (16,279) | ||
| Income (loss) from continuing operations before income taxes: | (9,076) | (6,408) | 816 | 148 | (7,147) | (960) | |
| Income tax expense (benefit) | 132 | 248 | (316) | (944) | (390) | ||
| Net income (loss): | (8,944) | (6,161) | 500 | (796) | (7,537) | (960) | |
| Other undisclosed net loss attributable to parent | (263) | ||||||
| Net income (loss) available to common stockholders, diluted: | (9,207) | (6,161) | 500 | (796) | (7,537) | (960) | |
Comprehensive Income ($ in thousands)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|
| Net income (loss): | (8,944) | (6,161) | 500 | (796) | (7,537) | (960) | |
| Comprehensive income (loss): | (8,944) | (6,161) | 500 | (796) | (7,537) | (960) | |
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (431) | 257 | (94) | 16 | |||
| Comprehensive income (loss), net of tax, attributable to parent: | (9,375) | (5,904) | 406 | (780) | (7,537) | (960) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.